(PAH3) Porsche Automobil Holding SE - Ratings and Ratios
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE000PAH0038
Sports Cars, Suvs, Sedans, Hybrids
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.81% |
| Yield on Cost 5y | 4.08% |
| Yield CAGR 5y | -16.71% |
| Payout Consistency | 84.6% |
| Payout Ratio | 20.6% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 22.0% |
| Value at Risk 5%th | 34.8% |
| Relative Tail Risk | -3.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.55 |
| Alpha | 10.27 |
| CAGR/Max DD | -0.14 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.457 |
| Beta | 0.131 |
| Beta Downside | 0.191 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.74% |
| Mean DD | 21.77% |
| Median DD | 21.84% |
Description: PAH3 Porsche Automobil Holding SE November 03, 2025
Porsche Automobil Holding SE (XETRA: PAH3) is the holding company for Volkswagen Group’s premium brands, including Volkswagen, Audi, SEAT, ŠKODA, Bentley, Lamborghini and Porsche. It reports under two segments-Core Investments (the operating automotive business) and Portfolio Investments (strategic stakes in mobility and industrial-technology firms). The firm, headquartered in Stuttgart, Germany, was renamed from Dr. Ing. h.c. F. Porsche AG in November 2007.
Key recent metrics show the Core Investments segment generated €85 billion in revenue in 2023, with an adjusted EBIT margin of 11.2 %, while EV sales accounted for roughly 23 % of total vehicle deliveries, reflecting accelerating electrification. The company’s exposure to the Chinese luxury market remains a material growth driver, but it is also vulnerable to EU CO₂-emission standards and tightening credit conditions that can suppress discretionary spending on high-end vehicles.
For a deeper, data-driven dive into Porsche PAH3’s valuation assumptions and scenario analysis, you might find ValueRay’s research platform a useful next step.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (-21.28b TTM) > 0 and > 6% of Revenue (6% = -1.29b TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA -0.77pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -9.61% (prev 42.85%; Δ -52.46pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 707.0m > Net Income -21.28b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 14.28 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (306.2m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 100.2% (prev -22.30%; Δ 122.5pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover -40.00% (prev 8.45%; Δ -48.45pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -61.22 (EBITDA TTM -21.51b / Interest Expense TTM 360.0m) >= 6 (WARN >= 3) |
Altman Z'' 4.43
| (A) 0.05 = (Total Current Assets 2.23b - Total Current Liabilities 156.0m) / Total Assets 42.85b |
| (B) 0.71 = Retained Earnings (Balance) 30.37b / Total Assets 42.85b |
| (C) -0.41 = EBIT TTM -22.04b / Avg Total Assets 53.88b |
| (D) 4.34 = Book Value of Equity 30.85b / Total Liabilities 7.12b |
| Total Rating: 4.43 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 27.86
| 1. Piotroski 2.50pt |
| 2. FCF Yield 4.31% |
| 3. FCF Margin -3.28% |
| 4. Debt/Equity 0.20 |
| 5. Debt/Ebitda -0.27 |
| 6. ROIC - WACC (= -64.82)% |
| 7. RoE -60.89% |
| 8. Rev. Trend -42.24% |
| 9. EPS Trend -47.62% |
What is the price of PAH3 shares?
As of December 28, 2025, the stock is trading at EUR 39.74 with a total of 277,896 shares traded.
Over the past week, the price has changed by -0.65%, over one month by +8.28%, over three months by +19.84% and over the past year by +16.20%.
Over the past week, the price has changed by -0.65%, over one month by +8.28%, over three months by +19.84% and over the past year by +16.20%.
Is PAH3 a buy, sell or hold?
Porsche Automobil Holding SE has no consensus analysts rating.
What are the forecasts/targets for the PAH3 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 40.5 | 1.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 43.4 | 9.3% |
PAH3 Fundamental Data Overview December 27, 2025
Market Cap USD = 12.58b (10.68b EUR * 1.1778 EUR.USD)
Market Cap EUR = 10.68b (10.68b EUR * 1.0 EUR.EUR)
P/E Forward = 2.8986
P/S = 1.1957
P/B = 0.3406
Beta = 1.066
Revenue TTM = -21.55b EUR
EBIT TTM = -22.04b EUR
EBITDA TTM = -21.51b EUR
Long Term Debt = 6.84b EUR (from longTermDebt, last quarter)
Short Term Debt = 124.0m EUR (from shortTermDebt, last quarter)
Debt = 6.97b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.70b EUR (from netDebt column, last quarter)
Enterprise Value = 16.38b EUR (10.68b + Debt 6.97b - CCE 1.26b)
Interest Coverage Ratio = -61.22 (Ebit TTM -22.04b / Interest Expense TTM 360.0m)
FCF Yield = 4.31% (FCF TTM 707.0m / Enterprise Value 16.38b)
WARNING: Negative Revenue TTM = -21.55b
FCF Margin = -3.28% (FCF TTM 707.0m / Revenue TTM -21.55b)
WARNING: Negative Revenue TTM = -21.55b
Net Margin = 98.76% (Net Income TTM -21.28b / Revenue TTM -21.55b)
WARNING: Negative Revenue TTM = -21.55b
Gross Margin = 100.2% ((Revenue TTM -21.55b - Cost of Revenue TTM 34.0m) / Revenue TTM)
Gross Margin QoQ = 98.73% (prev 99.34%)
Tobins Q-Ratio = 0.38 (Enterprise Value 16.38b / Total Assets 42.85b)
Interest Expense / Debt = 1.02% (Interest Expense 71.0m / Debt 6.97b)
Taxrate = -1.12% (negative due to tax credits) (-10.0m / 892.0m)
NOPAT = -22.28b (EBIT -22.04b * (1 - -1.12%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 14.28 (Total Current Assets 2.23b / Total Current Liabilities 156.0m)
Debt / Equity = 0.20 (Debt 6.97b / totalStockholderEquity, last quarter 35.73b)
Debt / EBITDA = -0.27 (negative EBITDA) (Net Debt 5.70b / EBITDA -21.51b)
Debt / FCF = 8.07 (Net Debt 5.70b / FCF TTM 707.0m)
Total Stockholder Equity = 34.96b (last 4 quarters mean from totalStockholderEquity)
RoA = -49.68% (Net Income -21.28b / Total Assets 42.85b)
RoE = -60.89% (Net Income TTM -21.28b / Total Stockholder Equity 34.96b)
RoCE = -52.72% (EBIT -22.04b / Capital Employed (Equity 34.96b + L.T.Debt 6.84b))
RoIC = -60.48% (negative operating profit) (NOPAT -22.28b / Invested Capital 36.85b)
WACC = 4.34% (E(10.68b)/V(17.65b) * Re(6.50%) + D(6.97b)/V(17.65b) * Rd(1.02%) * (1-Tc(-0.01)))
Discount Rate = 6.50% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈1.05b ; Y1≈690.8m ; Y5≈315.9m
Fair Price DCF = 40.55 (DCF Value 6.21b / Shares Outstanding 153.1m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -47.62 | EPS CAGR: 3.28% | SUE: 0.01 | # QB: 0
Revenue Correlation: -42.24 | Revenue CAGR: -19.93% | SUE: 0.07 | # QB: 0
EPS next Year (2026-12-31): EPS=14.43 | Chg30d=+0.142 | Revisions Net=-1 | Growth EPS=+46.2% | Growth Revenue=+0.0%
Market Cap EUR = 10.68b (10.68b EUR * 1.0 EUR.EUR)
P/E Forward = 2.8986
P/S = 1.1957
P/B = 0.3406
Beta = 1.066
Revenue TTM = -21.55b EUR
EBIT TTM = -22.04b EUR
EBITDA TTM = -21.51b EUR
Long Term Debt = 6.84b EUR (from longTermDebt, last quarter)
Short Term Debt = 124.0m EUR (from shortTermDebt, last quarter)
Debt = 6.97b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.70b EUR (from netDebt column, last quarter)
Enterprise Value = 16.38b EUR (10.68b + Debt 6.97b - CCE 1.26b)
Interest Coverage Ratio = -61.22 (Ebit TTM -22.04b / Interest Expense TTM 360.0m)
FCF Yield = 4.31% (FCF TTM 707.0m / Enterprise Value 16.38b)
WARNING: Negative Revenue TTM = -21.55b
FCF Margin = -3.28% (FCF TTM 707.0m / Revenue TTM -21.55b)
WARNING: Negative Revenue TTM = -21.55b
Net Margin = 98.76% (Net Income TTM -21.28b / Revenue TTM -21.55b)
WARNING: Negative Revenue TTM = -21.55b
Gross Margin = 100.2% ((Revenue TTM -21.55b - Cost of Revenue TTM 34.0m) / Revenue TTM)
Gross Margin QoQ = 98.73% (prev 99.34%)
Tobins Q-Ratio = 0.38 (Enterprise Value 16.38b / Total Assets 42.85b)
Interest Expense / Debt = 1.02% (Interest Expense 71.0m / Debt 6.97b)
Taxrate = -1.12% (negative due to tax credits) (-10.0m / 892.0m)
NOPAT = -22.28b (EBIT -22.04b * (1 - -1.12%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 14.28 (Total Current Assets 2.23b / Total Current Liabilities 156.0m)
Debt / Equity = 0.20 (Debt 6.97b / totalStockholderEquity, last quarter 35.73b)
Debt / EBITDA = -0.27 (negative EBITDA) (Net Debt 5.70b / EBITDA -21.51b)
Debt / FCF = 8.07 (Net Debt 5.70b / FCF TTM 707.0m)
Total Stockholder Equity = 34.96b (last 4 quarters mean from totalStockholderEquity)
RoA = -49.68% (Net Income -21.28b / Total Assets 42.85b)
RoE = -60.89% (Net Income TTM -21.28b / Total Stockholder Equity 34.96b)
RoCE = -52.72% (EBIT -22.04b / Capital Employed (Equity 34.96b + L.T.Debt 6.84b))
RoIC = -60.48% (negative operating profit) (NOPAT -22.28b / Invested Capital 36.85b)
WACC = 4.34% (E(10.68b)/V(17.65b) * Re(6.50%) + D(6.97b)/V(17.65b) * Rd(1.02%) * (1-Tc(-0.01)))
Discount Rate = 6.50% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈1.05b ; Y1≈690.8m ; Y5≈315.9m
Fair Price DCF = 40.55 (DCF Value 6.21b / Shares Outstanding 153.1m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -47.62 | EPS CAGR: 3.28% | SUE: 0.01 | # QB: 0
Revenue Correlation: -42.24 | Revenue CAGR: -19.93% | SUE: 0.07 | # QB: 0
EPS next Year (2026-12-31): EPS=14.43 | Chg30d=+0.142 | Revisions Net=-1 | Growth EPS=+46.2% | Growth Revenue=+0.0%